These substrates are often linked to oncogenic pathways such as the tumour suppressor PTEN, the oncogene OCT4 (octamer-binding transcription factor 4), genome stability components, the Wnt pathway, the EGFR (epidermal growth factor receptor) pathway and the TGFβ (transforming growth factor-β) pathway [12]. Here, EGFR is linked to neoplasm.